Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03765580
Other study ID # REC/16/0077
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date May 31, 2017

Study information

Verified date December 2018
Source University of Ulster
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Polyunsaturated fatty acids (PUFA) are important for health, for example for the immune system, heart health and the brain. PUFA are found in fish, nuts and oils; including these foods in the diet provides the body with PUFA. The body can also produce some PUFA in a series of steps. It has been found that genetics influences the levels of PUFA produced in the body. This study will investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype by conducting a controlled human intervention study. Participants will be asked to consume none, one or two portions of oily fish per week for 8 weeks and their response in PUFA status measured. This study will also use collected blood, hair, urine and faecal samples collected from the intervention study to explore other biomarkers of fish consumption. The aim of this study is to investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype and to explore the potential of a novel biomarker, using hair MeHg:δ34S values, to accurately predict fish consumption. The study will initially involve providing a buccal swab sample which will investigate genes which are related to fatty acids. The participant will provide a buccal swab sample so that their genotype can be determined. The researcher who will contact the participant once genotype has been determined to arrange a baseline appointment. Participants will attend the Human Intervention Studies Unit at Ulster University, Coleraine once or twice weekly for a period of 8 weeks where they will receive lunch. This lunch will contain either tuna, sardines, or no fish depending on the intervention group you will be allocated to. Examples of lunch time meals they may receive include sandwiches, baked potato or salad which will include the type of fish they have been allocated to receive. Those allocated to the no fish group will receive a fish free alternative lunch. Participants will be asked to continue to follow their normal diet and lifestyle over the intervention period of 8 weeks. All participants will attend a baseline and post intervention appointment where they will have weight, height and body composition measured. Participants will also complete questionnaires to provide medical, lifestyle and dietary information. All participants will be asked to provide a sample of blood, urine, hair and faeces to assess biomarkers of fish consumption at baseline and post intervention appointments. Collected blood, urine, hair and faecal samples will be analysed for biomarkers of fish consumption. Participants will also be asked to return to the Human Intervention Studies Unit (HISU) 8 weeks after the intervention study has been completed (week 16) to provide a third hair sample and complete a Fish Feedback Questionnaire. In the 8 wks following conclusion of the study they will be free to return to their normal diet.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date May 31, 2017
Est. primary completion date May 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Healthy females - premenopausal, child-bearing age, not planning to become pregnant

- Age 18-45years old

- Low consumers of fish (<2 portions/ week) or those willing to reduce their fish consumption one month prior to commencing the study to the equivalent of 2 portions per month or less

- Willing to eat 1 or 2 portions (140 grams or 280 grams) of either tuna or sardines per week for a period of 8 weeks

- Not consuming fish oil supplements

- Not consuming protein supplements

- Not allergic to seafood

Exclusion Criteria:

- Regularly eat fish or not willing to do washout period where they reduce fish consumption

- Are allergic to seafood

- Are taking fish oil supplements or are taking protein supplements

- Are pregnant or menopausal

- Have very short hair (a small section of hair, approximately 200 strands, will be taken at the nap of the neck for analysis purposes)

Study Design


Related Conditions & MeSH terms

  • Polyunsaturated Fatty Acid (PUFA) Status

Intervention

Dietary Supplement:
Fish
Lunch containing fish
Other:
Control
Lunch containing no fish

Locations

Country Name City State
United Kingdom Human Intervention Studies Unit, Ulster University Coleraine Co.Londonderry

Sponsors (4)

Lead Sponsor Collaborator
University of Ulster Lund University, Ministry of Health, Republic of Seychelles, University of Rochester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Polyunsaturated fatty acid (PUFA) status Serum Polyunsaturated fatty acid (PUFA) status Change at 8 weeks from baseline
Secondary Hair mercury Hair mercury status Change at 8 & 16 weeks from baseline
Secondary Lipid profile Serum lipid profile Change at 8 weeks from baseline
Secondary Iodine Urine iodine Change at 8 weeks from baseline
Secondary Inflammatory status Cytokine concentration (Interleukin (IL)-5, IL-1ß, IL-2, IL-4, IL-6, IL-10, MCP-1, TARC, sFlt-1, VEgF-D, CRP, TNF-a, IFN-?) Change at 8 weeks from baseline
Secondary Oxidative stress Change in glutathione peroxidase and 8-isoprostanes Change at 8 weeks from baseline
Secondary Microbiota Faecal microbiota profile Change at 8 weeks from baseline
Secondary Thyroid hormones Serum T3, T4 and thyroid-stimulating hormone (TSH). Dried blood spot for thyroglobulin, T4 and TSH Change at 8 weeks from baseline
Secondary Stable isotopes Hair methyl-mercury and sulphur-34 Change at 8 & 16 weeks from baseline
Secondary Methyl-mercury (MeHg) Whole blood and urine MeHg Change at 8 weeks from baseline